These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 38466558)

  • 1. The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis.
    Culpepper L; Martin A; Nabulsi N; Parikh M
    Adv Ther; 2024 May; 41(5):1860-1884. PubMed ID: 38466558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Cross-Sectional Analysis of the Humanistic and Economic Burden of Bipolar I Disorder.
    Culpepper L; Martin A; Harrington A; Wade SW; Parikh M
    Clin Ther; 2024 Nov; 46(11):855-864. PubMed ID: 39322443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic and humanistic burden of bipolar disorder in adults in the United States.
    Dembek C; Mackie D; Modi K; Zhu Y; Niu X; Grinnell T
    Ann Gen Psychiatry; 2023 Mar; 22(1):13. PubMed ID: 36964564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the severity of hypoglycemia on health - Related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes.
    Pawaskar M; Iglay K; Witt EA; Engel SS; Rajpathak S
    J Diabetes Complications; 2018 May; 32(5):451-457. PubMed ID: 29496365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matched Comparison Examining the Effect of Obesity on Clinical, Economic, and Humanistic Outcomes in Patients with Bipolar I Disorder.
    Doane MJ; Jauregui A; Panchmatia HR
    Adv Ther; 2024 Oct; 41(10):3807-3819. PubMed ID: 39115592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis.
    Jain S; Gupta S; Li VW; Suthoff E; Arnaud A
    BMC Psychiatry; 2022 Aug; 22(1):542. PubMed ID: 35953786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and burden of chronic insomnia disorder in Europe: an analysis of the 2020 National Health and Wellness Survey.
    Chalet FX; Albanese E; Egea Santaolalla C; Ellis JG; Ferini-Strambi L; Heidbreder A; Léger D; Modi K; Morin CM; Olopoenia A
    J Med Econ; 2024; 27(1):1308-1319. PubMed ID: 39318277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?
    Pilon D; Sheehan JJ; Szukis H; Morrison L; Zhdanava M; Lefebvre P; Joshi K
    J Affect Disord; 2019 Aug; 255():50-59. PubMed ID: 31128505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reporting Moderately Severe or Severe Major Depressive Disorder in a National Survey.
    Benson C; Singer D; Carpinella CM; Shawi M; Alphs L
    Neuropsychiatr Dis Treat; 2021; 17():111-123. PubMed ID: 33500620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
    Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B
    J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
    Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
    Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey data.
    Le HH; Ken-Opurum J; LaPrade A; Maculaitis MC; Sheehan JJ
    Mult Scler Relat Disord; 2022 Sep; 65():103971. PubMed ID: 35843012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
    Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
    J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States-based retrospective claims database analysis.
    Bangalore S; Shah R; Gao X; Pappadopulos E; Deshpande CG; Shelbaya A; Prieto R; Stephens J; Chambers R; Schepman P; McIntyre RS
    J Med Econ; 2020 Mar; 23(3):262-270. PubMed ID: 31665949
    [No Abstract]   [Full Text] [Related]  

  • 15. The burden of caring for adults with depression and suicidal ideation in five large European countries: analysis from the 2020 National Health and Wellness Survey.
    Jaffe DH; Balkaran BL; Yue L; Mulhern-Haughey S; Anjo J
    BMC Psychiatry; 2021 Nov; 21(1):550. PubMed ID: 34753436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions.
    Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
    J Manag Care Spec Pharm; 2020 Aug; 26(8):996-1007. PubMed ID: 32552362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
    Birnbaum HG; Kessler RC; Kelley D; Ben-Hamadi R; Joish VN; Greenberg PE
    Depress Anxiety; 2010; 27(1):78-89. PubMed ID: 19569060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental decreases in quality-adjusted life years (QALY) associated with higher levels of depressive symptoms for U.S. Adults aged 65 years and older.
    Jia H; Lubetkin EI
    Health Qual Life Outcomes; 2017 Jan; 15(1):9. PubMed ID: 28077154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual costs among patients with major depressive disorder and the impact of key clinical events.
    Cutler AJ; Keyloun KR; Higa S; Park J; Bonafede M; Gillard P; Jain R
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1335-1343. PubMed ID: 36427344
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient-Reported and Economic Racial and Ethnic Disparities in Patients with Psoriatic Arthritis: Results from the National Health and Wellness Survey.
    Lin I; Krupsky K; Way N; Patel AA; Tieng A
    Rheumatol Ther; 2024 Dec; 11(6):1569-1590. PubMed ID: 39343841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.